What's breaking now, across thousands of outlets.
AbbVie is licensing Nxera Pharma’s EP4 receptor agonist program for $100 million upfront, with up to $1.37 billion at stake in development and commercial milestones. Through its UK subsidiary, Tokyo-based Nxera will hand over global ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A bench of Justices Vikram Nath, Sandeep Mehta and Aparesh Kumar Singh was hearing the petition challenging a June 2017 order of the Kerala High Court.
Asked about the death of 11 milch cows in Salem district, Ms. Kamali said the deaths could have been caused by a bacterial infection. Ms. Kamali also denied reports of bird flu in Namakkal district.
Early diagnosis of dementia and Alzheimer's is a key factor as two new therapies that could soon be available to the Canadian public.
By Jennifer Nerkie Kenney Pregnant women have been urged to begin antenatal care immediately after confirming their pregnancies to reduce the risk of malaria-related complications for themselves and…
A new study from researchers at Boston Medical Center (BMC) found that Massachusetts neighborhoods given the lowest grades on historic redlining maps had 86% higher annual opioid-related overdose…
A new study led by researchers at The University of Hong Kong (HKU) has established the first systematic weekly benchmarks for green space exposure and mental health.
